| AMR | Antimicrobial Resistance |
| API | Active Pharmaceutical Ingredient |
| ATC | Anatomical Therapeutic Chemical Classification System |
| CAGR | Compound Annual Growth Rate |
| CIS | Commonwealth of Independent States |
| COX-2 | Cyclooxygenase-2 |
| DFU | Diabetic Foot Ulcer |
| DHPM | Dihydropyrimidine |
| EAEU | Eurasian Economic Union |
| FIR | Form Innovation Ratio |
| GMP | Good Manufacturing Practice |
| IL-6 | Interleukin-6 |
| INN | International Nonproprietary Name |
| JAK | Janus Kinase |
| LOX | Lipoxygenase |
| MCR3 | Market Concentration Ratio (top three categories) |
| mPGES-1 | Microsomal Prostaglandin E Synthase-1 |
| NSAIDs | Non-Steroidal Anti-Inflammatory Drugs |
| ROS | Reactive Oxygen Species |
| SPS | Strategic Priority Score |
| TGR | Therapeutic Gap Ratio |
| TMI | Technological Maturity Index (proportion of modern dosage forms; descriptive structural indicator) |
| TNF-α | Tumour Necrosis Factor Alpha |
| TS | Traditional Dosage Forms |
| WHO | World Health Organization |